We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$2.03B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
9.48%
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Technology 6.61%
3 Industrials 5.39%
4 Communication Services 5.27%
5 Consumer Discretionary 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$249M 12.26%
851,000
+2,700
+0.3% +$777K
SPY icon
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$180M 8.84%
613,600
+490,100
+397% +$141M
CELG
3
DELISTED
Celgene Corp
CELG
$45.3M 2.23%
490,200
-12,538
-2% -$1.19M
APC
4
DELISTED
Anadarko Petroleum
APC
$41.9M 2.06%
+593,600
New +$39.8M
RHT
5
DELISTED
Red Hat Inc
RHT
$37.8M 1.86%
201,272
-46,618
-19% -$8.6M
AABA
6
DELISTED
Altaba Inc
AABA
$36.1M 1.77%
520,138
-111,015
-18% -$7.77M
AGN
7
DELISTED
Allergan plc
AGN
$33M 1.62%
197,255
+196,435
+23,955% +$27.2M
VSM
8
DELISTED
Versum Materials, Inc.
VSM
$27.8M 1.37%
539,473
+318,981
+145% +$16.5M
QQQ icon
9
PUT
Invesco QQQ Trust
QQQ
$453B
$27.4M 1.35%
146,800
+69,600
+90% +$12.8M
ARRY
10
DELISTED
Array Biopharma Inc
ARRY
$26.1M 1.29%
+564,244
New +$15.8M
FDC
11
DELISTED
First Data Corporation
FDC
$25.5M 1.25%
941,088
-82,247
-8% -$2.14M
QQQ icon
12
CALL
Invesco QQQ Trust
QQQ
$453B
$24.6M 1.21%
131,800
+109,400
+488% +$20.1M
ONCE
13
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$24M 1.18%
234,250
+128,681
+122% +$13.9M
BID
14
DELISTED
Sotheby's
BID
$23.7M 1.17%
+408,244
New +$17.1M
LQD icon
15
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$22.9M 1.13%
184,018
+77,552
+73% +$9.31M
TRCO
16
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$22.5M 1.1%
485,767
+41,670
+9% +$1.93M
WCG
17
DELISTED
Wellcare Health Plans, Inc.
WCG
$22.1M 1.09%
77,435
+27,597
+55% +$7.61M
GOOGL icon
18
CALL
Alphabet (Google) Class A
GOOGL
$4.36T
$18.9M 0.93%
350,000
+262,000
+298% +$15.2M
S
19
DELISTED
Sprint Corporation
S
$14M 0.69%
2,131,796
+640,048
+43% +$4.04M
CZR
20
DELISTED
Caesars Entertainment Corporation
CZR
$12.8M 0.63%
1,083,696
+972,683
+876% +$9.22M
IWM icon
21
PUT
iShares Russell 2000 ETF
IWM
$79.8B
$11.1M 0.55%
71,300
+13,500
+23% +$2.08M
EFII
22
DELISTED
Electronics for Imaging
EFII
$11M 0.54%
299,109
+296,179
+10,108% +$10.6M
AAPL icon
23
PUT
Apple
AAPL
$4.54T
$10.3M 0.51%
208,800
+44,800
+27% +$2.18M
HYG icon
24
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$10.3M 0.5%
117,680
-117
-0.1% -$10.1K
STI
25
DELISTED
SunTrust Banks, Inc.
STI
$9.81M 0.48%
156,125
+115,956
+289% +$7.29M

Similar funds

Prelude Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.

  • Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
  • Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
  • Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
  • Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
  • Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
  • Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.